Bristol Myers Squibb Acquires RayzeBio, Expands with Actinium Radiopharmaceuticals

Bristol Myers Squibb (NYSE: BMY) announced that it has successfully completed its acquisition of RayzeBio, Inc. (NASDAQ: RYZB). With the completion of the ...

February 27, 2024 | Tuesday | News
Bitterroot Bio and Biotheus Launch Joint Effort to Create Bispecific Proteins for Cardio-Immunology

Bitterroot Bio, a leader in innovative treatments for cardiovascular diseases, and Biotheus, a pioneer in monoclonal and multi-specific antibody design, an...

February 27, 2024 | Tuesday | News
FDA Approves Groundbreaking SIMLANDI as First Interchangeable, High-Concentration Biosimilar to Humira

SIMLANDI is the first citrate-free, high-concentration biosimilar to be designated interchangeable to Humira in the U.S. SIMLANDI is the first biosimil...

February 26, 2024 | Monday | News
Aleta Biotherapeutics and Cancer Research UK Launch ALETA-001 Phase 1/2 Trial for Relapsed B-Cell Malignancies

Aleta Biotherapeutics (Aleta), a pioneer in immuno-oncology with a focus on CAR T-Cell Engager (CTE) platforms, in collaboration with Cancer Research UK&rs...

February 21, 2024 | Wednesday | News
Dyadic International, Inc. Teams Up with Israel Institute for Biological Research to Combat Emerging Diseases and Bio-Threats

Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a prominent global biotechnology company specializing in advanced microbial platform...

February 21, 2024 | Wednesday | News
Biocytogen Pharmaceuticals Announces Antibody Evaluation and Option Agreement with Gilead Sciences

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315)  announces an antibody evaluation and option agreement with Gil...

February 20, 2024 | Tuesday | News
Roche Diagnostics and BioPorto Announce Expanded Collaboration

    ProNephro AKI (NGAL) stands out as the first AKI biomarker test to secure FDA clearance for pediatric use, covering children from...

February 20, 2024 | Tuesday | News
Daiichi Sankyo and AstraZeneca's Datopotamab Deruxtecan BLA Accepted in U.S. for Advanced Nonsquamous NSCLC Treatment

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have announced the acceptance of their Biologics License Application (BLA) for datopotamab...

February 19, 2024 | Monday | News
Intellia Therapeutics and ReCode Therapeutics Forge Partnership to Combat Cystic Fibrosis

  CF, a genetic disorder triggered by mutations in the CFTR gene, leads to the accumulation of thick mucus in vital organs such as the lungs and dige...

February 16, 2024 | Friday | News
dsm-firmenich Forges Exclusive Partnership with ZERION Pharma A/S to Pioneer Patient-Centric Cannabinoid Formulations

The partnership grants dsm-firmenich global access to ZERION A/S’s unique, cutting-edge Dispersome® technology, developed with the aim of signifi...

February 15, 2024 | Thursday | News
Roche Collaborates with PathAI to Enhance Digital Pathology Capabilities for Companion Diagnostics

PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD's companion...

February 13, 2024 | Tuesday | News
Medidata and Sanofi Vaccines Forge Deeper Collaboration to Enhance Patient Centricity and Trial Efficiency

Medidata, a Dassault Systèmes company and a leading provider of clinical trial solutions to the life sciences industry, has joined forces with Sanof...

February 07, 2024 | Wednesday | News
Purolite & Repligen Launch New CH1 Affinity Resin for Specialized mAb Purification

This latest innovation, which was developed for commercialization by Purolite as part of a multi-year strategic partnership with Repligen, combines Purolit...

February 06, 2024 | Tuesday | News
RevoluGen and LGC Biosearch Showcase Advanced DNA Extraction with Fire Monkey Chemistry

Under a collaboration with LGC Biosearch TechnologiesTM, RevoluGen has coupled its Fire Monkey chemistry with LGC magnetic beads and LGC oKtopureTM liquid ...

January 30, 2024 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in